Explore the Committee on Ways and Means' findings on hospital costs, Medicare expenditure, and policy reforms to manage escalating healthcare prices.

U.S. federal agencies issue new guidance and requests for information to improve transparency in prescription drug and hospital prices, aiming to enhance data accuracy and compliance.